|
DMTF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.41310313345389E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.49079999853552E-08 |
| Normal-vs-Stage2 |
2.142500E-02 |
| Normal-vs-Stage3 |
4.312000E-01 |
| Normal-vs-Stage4 |
1.608440E-01 |
| Stage1-vs-Stage2 |
9.077400E-01 |
| Stage1-vs-Stage3 |
1.80958999999037E-05 |
| Stage1-vs-Stage4 |
7.812100E-02 |
| Stage2-vs-Stage3 |
4.115700E-02 |
| Stage2-vs-Stage4 |
2.116000E-01 |
| Stage3-vs-Stage4 |
2.452600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.26969998351478E-10 |
| Normal-vs-AfricanAmerican |
2.194900E-04 |
| Normal-vs-Asian |
2.492800E-01 |
| Caucasian-vs-AfricanAmerican |
6.513200E-01 |
| Caucasian-vs-Asian |
3.089200E-01 |
| AfricanAmerican-vs-Asian |
3.915400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62839741690846E-11 |
| Normal-vs-Female |
7.764100E-04 |
| Male-vs-Female |
1.458350E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.839900E-03 |
| Normal-vs-Extreme_Weight |
1.69344999999543E-05 |
| Normal-vs-Obese |
4.11120000000098E-05 |
| Normal-vs-Extreme_Obese |
1.640030E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.794600E-01 |
| Normal_Weight-vs-Obese |
4.809400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.787400E-01 |
| Extreme_Weight-vs-Obese |
8.076000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.339000E-01 |
| Obese-vs-Extreme_Obese |
8.013400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.267700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.11040004863372E-09 |
| Normal-vs-Age(61-80Yrs) |
3.76649999966894E-07 |
| Normal-vs-Age(81-100Yrs) |
3.711000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.322600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.965200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.599000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.200950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.662630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.856400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.44089209850063E-16 |
| Normal-VS-Type2 PRCC |
8.029400E-01 |
| Normal-VS-KIRP CIMP |
8.000200E-01 |
| Normal-VS-Unclassified PRCC |
3.484500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
<1E-12 |
| Type1 PRCC-VS-KIRP CIMP |
2.79199996455759E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
1.340800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.544000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.984850E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.636300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.421770E-02 |
| Normal-vs-N1 |
6.086100E-02 |
| Normal-vs-N2 |
4.220800E-01 |
| N0-vs-N1 |
4.838000E-01 |
| N0-vs-N2 |
3.021900E-03 |
| N1-vs-N2 |
1.867010E-01 |
|
|
